Chancellor Rachel Reeves Intends Targeted Measures on Household Expenses in Forthcoming Budget

Chancellor Rachel Reeves has revealed she is planning "specific action to tackle household expense issues" in the upcoming Budget.

Speaking to media outlets, she stated that reducing price rises is a joint duty of both the administration and the central bank.

The UK's inflation rate is expected to be the highest among the G7 advanced economies this year and the following year.

Possible Utility Bill Interventions

It is understood the administration could intervene to lower energy bills, for instance by slashing the present 5% rate of value-added tax charged on energy supplies.

A further possibility is to cut some of the policy costs presently included in household expenses.

Budgetary Limitations and Expert Predictions

The administration will obtain the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these actions.

The consensus from the majority of analysts is that Reeves will have to introduce higher taxes or expenditure reductions in order to fulfill her voluntary borrowing rules.

Previously on the same day, analysis indicated there was a £22 billion gap for the chancellor to fill, which is at the lower end of forecasts.

"There's a shared responsibility between the central bank and the government to bear down further on some of the drivers of inflation," the Chancellor stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Commitments and Global Issues

While a great deal of the focus has been on likely tax increases, the Treasury chief said the most recent data from the fiscal watchdog had not changed her commitment to election pledges not to raise tax levels on income tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with increasing international and commercial concerns for the fiscal revenue measures, probably to be focused on those "wealthiest."

Global Trade Disputes

Commenting on apprehensions about the UK's economic relations with China she said: "Our national security invariably come first."

Recent declaration by China to increase trade restrictions on critical minerals and other resources that are essential for advanced tech manufacturing led American leader the US President to threaten an additional 100% tariff on goods from the Asian country, raising the prospect of an all-out trade war between the two economic giants.

The US Treasury Secretary called China's move "economic coercion" and "a international production control attempt."

Questioned on considering the US offer to join its conflict with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the move was "harmful for the world economy and causes further headwinds."

"I believe there are areas where we should challenge China, but there are also significant opportunities to trade with Chinese markets, including financial services and other areas of the economic system. We've got to get that balance correct."

The Treasury chief also confirmed she was working with G7 counterparts "regarding our own critical minerals strategy, so that we are more independent."

NHS Medicine Costs and Investment

The Chancellor also acknowledged that the price the NHS pays for pharmaceuticals could go up as a result of ongoing talks with the US government and its pharmaceutical firms, in exchange for lower tariffs and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or scrapping projects in the UK, with several blaming the insufficient payments they are obtaining.

Recently, the Science Minister said the price the NHS pays for drugs would must go up to halt companies and pharmaceutical investment leaving the UK.

The Chancellor told media: "It has been observed because of the payment system, that medical research, innovative medicines have not been provided in the UK in the extent that they are in other EU nations."

"The objective is to ensure that people getting care from the National Health Service are able to obtain the best life-saving treatments in the world. And so we are examining this situation, and... looking to secure additional funding into Britain."

Christina Carpenter
Christina Carpenter

Financial analyst with over a decade of experience in global markets, specializing in equity and forex trading strategies.